Stereotaxis, Inc. (STXS) |
| 0.8626 -0.047 (-5.21%) 10-30 16:00 |
| Open: | 0.8999 |
| High: | 0.9183 |
| Low: | 0.8152 |
| Volume: | 1,440,830 |
| Market Cap: | 86(M) |
| PE Ratio: | -5.07 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.32 |
| Resistance 1: | 1.13 |
| Pivot price: | 1.01 |
| Support 1: | 0.82 |
| Support 2: | 0.68 |
| 52w High: | 2.93 |
| 52w Low: | 0.81 |
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 30 Oct 2026
Canon imaging will be offered alongside a robot designed for existing labs, with no construction. - Stock Titan
Fri, 23 Oct 2026
Stereotaxis, Inc. Estimates – AMEX:STXS - TradingView
Thu, 22 Oct 2026
Latvia's first robotic heart-rhythm program has treated its first patients - Stock Titan
Tue, 20 Oct 2026
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026 - Yahoo Finance
Fri, 16 Oct 2026
Stereotaxis, Inc. (STXS) Stock Price & News - Syfe
Wed, 19 Aug 2026
New >5% shareholder emerges in Stereotaxis (STXS) stock - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
